United States Biotechnology & Medical Research

PPD Inc (PPD)

Track

Track

Ticker: PPD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
SIMMONS DAVID S Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
42.00
Quantity 100,000 -14.9%
Value US$4,200,000
Johnston David Michael See Remarks Officer
Transaction date
Planned sale
Price
38.00
Quantity 21,598 -37.9%
Value US$820,724
3.0
SIMMONS DAVID S Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
38.00
Quantity 22,935 -3.3%
Value US$871,530
Donovan Glen Chief Accounting Officer Officer
Transaction date
Sale
Price
35.62
Quantity 16,347 -84.5%
Value US$582,280
Garrow Ronald E See Remarks Officer
Transaction date
Sale
Price
36.38
Quantity 69,401 -100.0%
Value US$2,524,808
Johnston David Michael See Remarks Officer
Transaction date
Planned sale
Price
36.29
Quantity 21,597 -37.9%
Value US$783,755
Johnston David Michael See Remarks Officer
Transaction date
Planned sale
Price
35.43
Quantity 39,297 -52.6%
Value US$1,392,293
3.0
SIMMONS DAVID S Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
38.01
Quantity 77,065 -10.0%
Value US$2,929,241
Kaucic Karen See Remarks Officer
Transaction date
Sale
Price
34.80
Quantity 20,574 -71.0%
Value US$715,975
HARTMAN JUDD See Remarks Officer
Transaction date
Sale
Price
34.60
Quantity 30,000 -31.9%
Value US$1,038,000
Donovan Glen Chief Accounting Officer Officer
Transaction date
Sale
Price
34.76
Quantity 2,833 -48.6%
Value US$98,475
Johnston David Michael See Remarks Officer
Transaction date
Sale
Price
33.11
Quantity 40,000 -43.0%
Value US$1,324,400
2.1
Hill Colin Non-Executive Director
Transaction date
Sale
Price
31.28
Quantity 1,722 -10.8%
Value US$53,868
Garrow Ronald E See Remarks Officer
Transaction date
Sale
Price
34.12
Quantity 9,500 -100.0%
Value US$324,140
Scully Christopher G. See Remarks Officer
Transaction date
Purchase
Price
27.00
Quantity 26,000 +inf%
Value US$702,000
3.0
SIMMONS DAVID S Chief Executive Officer Executive Director
Transaction date
Purchase
Price
27.00
Quantity 40,000 +4.6%
Value US$1,080,000
Donovan Glen Chief Accounting Officer Officer
Transaction date
Purchase
Price
27.00
Quantity 500 +9.4%
Value US$13,500
Sharbaugh William J Chief Operating Officer Officer
Transaction date
Purchase
Price
27.00
Quantity 30,000 +9.0%
Value US$810,000
Fikry Christopher See Remarks Officer
Transaction date
Purchase
Price
27.00
Quantity 7,400 +111.4%
Value US$199,800
2.7
Hilado Maria Teresa Non-Executive Director
Transaction date
Purchase
Price
27.00
Quantity 8,000 +31.4%
Value US$216,000
2.4
KINDLER JEFFREY B Non-Executive Director
Transaction date
Purchase
Price
27.00
Quantity 18,500 +19.8%
Value US$499,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
29,687 +16.5%
373.12
US$3,074,065 		29,687 +16.5% 373.12 US$3,074,065
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
11,812 +40.6%
103.91
US$4,853,971 		11,812 +40.6% 103.91 US$4,853,971
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
8,579 -41.0%
243.67
US$3,393,254 		8,579 -41.0% 243.67 US$3,393,254
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
15,987,409 -100.0%
47.50
US$759,401,928 		15,987,409 -100.0% 47.50 US$759,401,928
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
35,622,429 -100.0%
47.50
US$1,692,065,378 		35,622,429 -100.0% 47.50 US$1,692,065,378
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
359,372 -100.0%
47.50
US$17,070,170 		359,372 -100.0% 47.50 US$17,070,170
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
3,630,740 -100.0%
47.50
US$172,460,150 		3,630,740 -100.0% 47.50 US$172,460,150
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
20,244,387 -100.0%
47.50
US$961,608,382 		20,244,387 -100.0% 47.50 US$961,608,382
2021-12-08 2021-12-08 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
52,884,036 -100.0%
47.50
US$2,511,991,710 		52,884,036 -100.0% 47.50 US$2,511,991,710
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
157,138 -100.0%
47.50
US$7,464,055 		157,138 -100.0% 47.50 US$7,464,055
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
934,469 -100.0%
47.50
US$44,387,278 		934,469 -100.0% 47.50 US$44,387,278
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,021,286 -100.0%
47.50
US$143,511,085 		3,021,286 -100.0% 47.50 US$143,511,085
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
15,987,409 -100.0%
47.50
US$759,401,928 		15,987,409 -100.0% 47.50 US$759,401,928
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
35,622,429 -100.0%
47.50
US$1,692,065,378 		35,622,429 -100.0% 47.50 US$1,692,065,378
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
359,372 -100.0%
47.50
US$17,070,170 		359,372 -100.0% 47.50 US$17,070,170
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,630,740 -100.0%
47.50
US$172,460,150 		3,630,740 -100.0% 47.50 US$172,460,150
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
20,244,387 -100.0%
47.50
US$961,608,382 		20,244,387 -100.0% 47.50 US$961,608,382
2021-12-08 2021-12-08 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
52,884,036 -100.0%
47.50
US$2,511,991,710 		52,884,036 -100.0% 47.50 US$2,511,991,710
2021-04-16 2021-04-14 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
100,000 -14.9%
42.00
US$4,200,000 		100,000 -14.9% 42.00 US$4,200,000
2021-03-18 2021-03-17 PlS Planned sale
Johnston David Michael

See Remarks

Officer
21,598 -37.9%
38.00
US$820,724 		21,598 -37.9% 38.00 US$820,724
2021-03-18 2021-03-17 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
22,935 -3.3%
38.00
US$871,530 		22,935 -3.3% 38.00 US$871,530
2021-03-05 2021-03-03 S Sale
Donovan Glen

Chief Accounting Officer

Officer
16,347 -84.5%
35.62
US$582,280 		16,347 -84.5% 35.62 US$582,280
2021-03-04 2021-03-02 S Sale
Garrow Ronald E

See Remarks

Officer
69,401 -100.0%
36.38
US$2,524,808 		69,401 -100.0% 36.38 US$2,524,808
2021-03-03 2021-03-02 PlS Planned sale
Johnston David Michael

See Remarks

Officer
21,597 -37.9%
36.29
US$783,755 		21,597 -37.9% 36.29 US$783,755
2021-03-03 2021-03-01 PlS Planned sale
Johnston David Michael

See Remarks

Officer
39,297 -52.6%
35.43
US$1,392,293 		39,297 -52.6% 35.43 US$1,392,293
2021-02-16 2021-02-12 PlS Planned sale
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
77,065 -10.0%
38.01
US$2,929,241 		77,065 -10.0% 38.01 US$2,929,241
2020-10-01 2020-09-29 S Sale
Kaucic Karen

See Remarks

Officer
20,574 -71.0%
34.80
US$715,975 		20,574 -71.0% 34.80 US$715,975
2020-10-01 2020-09-29 S Sale
HARTMAN JUDD

See Remarks

Officer
30,000 -31.9%
34.60
US$1,038,000 		30,000 -31.9% 34.60 US$1,038,000
2020-09-24 2020-09-22 S Sale
Donovan Glen

Chief Accounting Officer

Officer
2,833 -48.6%
34.76
US$98,475 		2,833 -48.6% 34.76 US$98,475
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
30,264 -16.1%
31.28
US$946,734 		30,264 -16.1% 31.28 US$946,734
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
179,980 -16.1%
31.28
US$5,630,224 		179,980 -16.1% 31.28 US$5,630,224
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
581,903 -16.1%
31.28
US$18,203,381 		581,903 -16.1% 31.28 US$18,203,381
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
3,079,193 -16.1%
31.28
US$96,324,855 		3,079,193 -16.1% 31.28 US$96,324,855
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
6,860,919 -16.1%
31.28
US$214,626,699 		6,860,919 -16.1% 31.28 US$214,626,699
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
69,215 -16.1%
31.28
US$2,165,218 		69,215 -16.1% 31.28 US$2,165,218
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
699,284 -16.1%
31.28
US$21,875,352 		699,284 -16.1% 31.28 US$21,875,352
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
3,899,092 -16.1%
31.28
US$121,973,345 		3,899,092 -16.1% 31.28 US$121,973,345
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
30,264 -16.1%
31.28
US$946,734 		30,264 -16.1% 31.28 US$946,734
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
179,980 -16.1%
31.28
US$5,630,224 		179,980 -16.1% 31.28 US$5,630,224
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
581,903 -16.1%
31.28
US$18,203,381 		581,903 -16.1% 31.28 US$18,203,381
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,079,193 -16.1%
31.28
US$96,324,855 		3,079,193 -16.1% 31.28 US$96,324,855
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
6,860,919 -16.1%
31.28
US$214,626,699 		6,860,919 -16.1% 31.28 US$214,626,699
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
69,215 -16.1%
31.28
US$2,165,218 		69,215 -16.1% 31.28 US$2,165,218
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
699,284 -16.1%
31.28
US$21,875,352 		699,284 -16.1% 31.28 US$21,875,352
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
3,899,092 -16.1%
31.28
US$121,973,345 		3,899,092 -16.1% 31.28 US$121,973,345
2020-09-23 2020-09-21 S Sale
1.1
H&F Corporate Investors VIII, Ltd.
Large shareholder
9,302,325 -14.7%
31.28
US$290,999,982 		9,302,325 -14.7% 31.28 US$290,999,982
2020-09-23 2020-09-21 S Sale
Johnston David Michael

See Remarks

Officer
40,000 -43.0%
33.11
US$1,324,400 		40,000 -43.0% 33.11 US$1,324,400
2020-09-23 2020-09-21 S Sale
2.1
H&F Corporate Investors VII, Ltd.
Large shareholder
9,302,325 -14.7%
31.28
US$290,999,982 		9,302,325 -14.7% 31.28 US$290,999,982
2020-09-23 2020-09-21 S Sale
2.1
Hill Colin
Non-Executive Director
1,722 -10.8%
31.28
US$53,868 		1,722 -10.8% 31.28 US$53,868
2020-09-22 2020-09-21 S Sale
2.2
Carlyle Group Management L.L.C.
Large shareholder
10,732,261 -16.1%
31.28
US$335,731,955 		10,732,261 -16.1% 31.28 US$335,731,955
2020-09-22 2020-09-18 S Sale
Garrow Ronald E

See Remarks

Officer
9,500 -100.0%
34.12
US$324,140 		9,500 -100.0% 34.12 US$324,140
2020-02-12 2020-02-10 B Purchase
Scully Christopher G.

See Remarks

Officer
26,000 +inf%
27.00
US$702,000 		26,000 +inf% 27.00 US$702,000
2020-02-12 2020-02-10 B Purchase
3.0
SIMMONS DAVID S

Chief Executive Officer

Executive Director
40,000 +4.6%
27.00
US$1,080,000 		40,000 +4.6% 27.00 US$1,080,000
2020-02-12 2020-02-10 B Purchase
Donovan Glen

Chief Accounting Officer

Officer
500 +9.4%
27.00
US$13,500 		500 +9.4% 27.00 US$13,500
2020-02-12 2020-02-10 B Purchase
Sharbaugh William J

Chief Operating Officer

Officer
30,000 +9.0%
27.00
US$810,000 		30,000 +9.0% 27.00 US$810,000
2020-02-12 2020-02-10 B Purchase
Fikry Christopher

See Remarks

Officer
7,400 +111.4%
27.00
US$199,800 		7,400 +111.4% 27.00 US$199,800
2020-02-12 2020-02-10 B Purchase
2.7
Hilado Maria Teresa
Non-Executive Director
8,000 +31.4%
27.00
US$216,000 		8,000 +31.4% 27.00 US$216,000
2020-02-12 2020-02-10 B Purchase
2.4
KINDLER JEFFREY B
Non-Executive Director
18,500 +19.8%
27.00
US$499,500 		18,500 +19.8% 27.00 US$499,500
Explore more

More insider trading research around PPD Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America